|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Washington Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing WashingtonLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Adaptive Biotechnologies Corporation
| | | Phone: | (206) 659-0067 | Year Established: | 2009 | Main Contact: | Julie Rubinstein, CBO | | Other Contacts: | Charles Sang, Senior VP, Diagnostics Gene DeFelice, Senior VP & General Counsel B. Melina Cimler, PhD, Senior VP, RA & QA Harlan Robins, PhD, Head of Innovation, Co-founder Sean Nolan, CTO Chad Cohen, CFO Nancy Hill, Senior VP, Operations and Marketing Chad Robins, M.B.A., Co-Founder, President & CEO
| | Company Description | Adaptive Biotechnologies (formerly Adaptive TCR Corp.) is a platform-based, diagnostic-driven company that leverages NGS to profile T-cell and B-cell Receptors. This breakthrough enables in-depth characterization of the adaptive immune system, which is the primary defense against cancer. By incorporating immunosequencing into clinical care, Adaptive can enhance the diagnosis, prognosis and monitoring of cancer patients.
Adaptive helps researchers make discoveries in oncology, autoimmune disorders and infectious diseases by offering fee-for-service access to its proprietary immune profiling sequencing technology, which is now available to facilitate the integration of immunosequencing into research centers. | |
|
|
|
|
|